An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.
The best Bull and Bear pitches based on recency and number of recommendations.
With approval of their once daily tramadol in the US, and pending approval of trazadone, this company has moved from being a speculative position to one where a profit becomes realizable in the not so distant future. Time will tell if management can… More
Drug delivery and reformulation is a crowded sector and requires branded life cycle extensions for strategies to be profitable
Read the most recent pitches from players about DDSSF.DL.P.
Find the members with the highest scoring picks in DDSSF.DL.P.
See what the Wall Street professionals think, according to their public statements and filings.